Search details
1.
Immunogenicity and clinical effectiveness of mRNA vaccine booster against SARS-CoV-2 Omicron in patients with haematological malignancies: A national prospective cohort study.
Br J Haematol
; 204(2): 497-506, 2024 02.
Article
in English
| MEDLINE | ID: mdl-37786970
2.
Outcomes of relapsed or refractory acute myeloid leukemia patients failing venetoclax-based salvage therapies.
Eur J Haematol
; 106(1): 105-113, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-32997830
3.
Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
Lancet Haematol
; 8(8): e583-e592, 2021 Aug.
Article
in English
| MEDLINE | ID: mdl-34224668
4.
Venetoclax-based salvage therapy followed by Venetoclax and DLI maintenance vs. FLAG-Ida for relapsed or refractory acute myeloid leukemia after allogeneic stem cell transplantation.
Bone Marrow Transplant
; 56(11): 2804-2812, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34274954
5.
Venetoclax in combination with low dose Cytarabine and Actinomycin D for primary refractory acute myeloid leukemia patients failing intensive chemotherapy.
Leuk Res
; 111: 106692, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34438121
Results
1 -
5
de 5
1
Next >
>>